BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11176229)

  • 1. Current status of prophylactic surgery for hereditary breast and gynecologic cancers.
    Lynch HT; Casey MJ
    Curr Opin Obstet Gynecol; 2001 Feb; 13(1):25-30. PubMed ID: 11176229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for prophylactic surgery for decreasing the risk of gynaecological cancer in women with hereditary risk].
    Zikán M; Kalábová R
    Klin Onkol; 2009; 22 Suppl():S58-9. PubMed ID: 19764400
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of genetic syndromes predisposing to gynecologic cancers.
    Miesfeldt S; Lamb A; Duarte C
    Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    Hall MJ; Obeid EI; Schwartz SC; Mantia-Smaldone G; Forman AD; Daly MB
    Gynecol Oncol; 2016 Mar; 140(3):565-74. PubMed ID: 26812021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary predispositions to gynaecological cancers].
    Coupier I; Pujol P
    Gynecol Obstet Fertil; 2005 Nov; 33(11):851-6. PubMed ID: 16256400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should women with a genetic predisposition for cancer be managed?
    Hoskins WJ
    Obstet Gynecol; 2007 Jul; 110(1):5-6. PubMed ID: 17601888
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
    Davidson BA; Moorman PG
    Expert Opin Drug Saf; 2014 Oct; 13(10):1375-82. PubMed ID: 25146351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.
    Chen LM; Blank SV; Burton E; Glass K; Penick E; Woodard T
    Fertil Steril; 2019 Dec; 112(6):1034-1042. PubMed ID: 31606136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.
    Ma IT; Gray RJ; Wasif N; Butler KA; Cornella JL; Magrina JF; Magtibay PM; Casey WJ; Mahabir R; Rebecca AM; Hunt KS; Pockaj BA
    Ann Surg Oncol; 2017 Jan; 24(1):77-83. PubMed ID: 27581610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of patients at inherited risk for gynecologic cancer.
    Powell CB
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):14-22. PubMed ID: 25490378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
    Brown GJ; St John DJ; Macrae FA; Aittomäki K
    Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.